Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study

[1]  A. A. Abdel Razek,et al.  Liver Imaging Reporting and Data System Version 2018: What Radiologists Need to Know , 2020, Journal of computer assisted tomography.

[2]  Versione,et al.  Common Terminology Criteria for Adverse Events , 2020, Definitions.

[3]  A. A. Abdel Razek,et al.  Interobserver Agreement of Magnetic Resonance Imaging of Liver Imaging Reporting and Data System Version 2018. , 2020, Journal of computer assisted tomography.

[4]  C. Catalano,et al.  Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results , 2019, CardioVascular and Interventional Radiology.

[5]  Rahul S. Patel,et al.  Balloon-Occluded Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single-Center US Preliminary Experience. , 2019, Journal of vascular and interventional radiology : JVIR.

[6]  C. Catalano,et al.  Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards. , 2019, Journal of vascular and interventional radiology : JVIR.

[7]  Robert M. Marks,et al.  White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI , 2018, Abdominal Radiology.

[8]  S. Kakizaki,et al.  Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma , 2018, World journal of hepatology.

[9]  M. Yamada,et al.  Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon‐occluded transcatheter arterial chemoembolization: A retrospective cohort study , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  C. Catalano,et al.  Single injection dual phase CBCT technique ameliorates results of trans-arterial chemoembolization for hepatocellular cancer. , 2017, Translational gastroenterology and hepatology.

[11]  Yoshinobu Yamamoto,et al.  Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short‐term results , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  T. Kamoshida,et al.  Selective balloon‐occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super‐selective TACE , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  H. Kitagaki,et al.  Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma , 2016, CardioVascular and Interventional Radiology.

[14]  Myeong-Jin Kim,et al.  Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. , 2015, Journal of hepatology.

[15]  Tomohiro Matsumoto,et al.  Balloon-occluded transarterial chemoembolization using a 1.8-French tip Coaxial microballoon catheter for hepatocellular carcinoma: Technical and safety considerations , 2015, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[16]  Lequn Li,et al.  Systematic review comparing the safety and efficacy of conventional and drug‐eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  K. Sung,et al.  Angiographic evaluation of hepatic arterial injury after cisplatin and Gelfoam-based transcatheter arterial chemoembolization for hepatocellular carcinoma in a 205 patient cohort during a 6-year follow-up. , 2014, The British journal of radiology.

[18]  J. Heimbach,et al.  Recurrence of Hepatocellular Carcinoma: Importance of mRECIST Response to Chemoembolization and Tumor Size , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  L. Bolondi,et al.  Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? , 2013, Journal of vascular and interventional radiology : JVIR.

[20]  N. Takahashi,et al.  Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure , 2013, CardioVascular and Interventional Radiology.

[21]  K. Sung,et al.  Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. , 2011, Journal of vascular and interventional radiology : JVIR.

[22]  M. Carpenzano,et al.  Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas , 2011, Hepatology.

[23]  J. Bruix,et al.  Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.

[24]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[25]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..